A Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now has early signs of efficacy along with safety data that ease some concerns about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback